Βιβλιογραφική Τεκμηρίωση:
Predictive role of RRM1 and BRCA1 mRNA expression on the clinical outcome of advanced non-small cell lung cancer. Liang JG, Jin ZY, Gao XD, Te MR, Ge LH, Wang CL. Genet Mol Res. 2014 Jul 24;13(3):5292-8. doi: 10.4238/2014.July.24.8.
The relationship between RRM1 gene polymorphisms and effectiveness of gemcitabine-based first-line chemotherapy in advanced NSCLC patient. Mlak R, Krawczyk P, Ciesielka M, Kozioł P, Homa I, Powrózek T, Prendecka M, Milanowski J, Małecka-Massalska T. Clin Transl Oncol. 2016 Sep;18(9):915-24. doi: 10.1007/s12094-015-1461-1. Epub 2015 Dec 9.
High RRM1 Expression Is Associated with Adverse Outcome in Patients with Cisplatin/Vinorelbine-treated Malignant Pleural Mesothelioma. Zimling ZG, Santoni-Rugiu E, Bech C, Sørensen JB. Anticancer Res. 2015 Dec;35(12):6731-8.
Charlotte LT Jørgensen, Bent Ejlertsen, Karsten D Bjerre, Eva Balslev, Dorte L Nielsen, Kirsten V Nielsen
BMC Cancer. 2013; 13: 541. Published online 2013 Nov 12. doi: 10.1186/1471-2407-13-541
RRM1[Ribonucleoside-diphosphate reductase large subunit]
